- Report
- July 2024
- 175 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- November 2024
- 319 Pages
Global
From €4483EUR$4,799USD£3,793GBP
- Report
- May 2024
- 224 Pages
Global
From €4483EUR$4,799USD£3,793GBP
- Report
- November 2024
- 1159 Pages
Global
€1835EUR$2,033USD£1,500GBP
- Report
- May 2024
- 1175 Pages
Global
€1835EUR$2,033USD£1,500GBP
- Report
- June 2024
- 569 Pages
Global
From €1346EUR$1,491USD£1,100GBP
- Report
- March 2025
- 219 Pages
Global
From €4344EUR$4,650USD£3,675GBP
- Report
- July 2024
- 100 Pages
Global
From €3503EUR$3,750USD£2,964GBP
- Report
- May 2021
- 358 Pages
Global
From €1285EUR$1,375USD£1,087GBP
€2569EUR$2,750USD£2,173GBP
- Report
- July 2023
- 70 Pages
Global
From €5559EUR$5,950USD£4,702GBP
- Report
- February 2024
- 250 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- February 2024
- 250 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- December 2019
- 120 Pages
Global
From €3457EUR$3,700USD£2,924GBP
- Report
- March 2024
- 200 Pages
Global
From €3877EUR$4,150USD£3,280GBP
- Report
- February 2024
- 116 Pages
Global
From €4438EUR$4,750USD£3,754GBP
- Report
- January 2022
- 115 Pages
Global
From €4438EUR$4,750USD£3,754GBP
- Report
- January 2024
- 242 Pages
Global
€4666EUR$4,995USD£3,948GBP
- Report
- January 2020
- 156 Pages
Japan
From €4204EUR$4,500USD£3,556GBP
- Report
- July 2023
- 112 Pages
Global
From €3500EUR$4,013USD£3,065GBP
- Book
- March 2021
- 320 Pages

Biobetter is a term used to describe biotechnology products that are designed to improve upon existing treatments or therapies. These products are typically developed through the use of genetic engineering, gene therapy, or other advanced biotechnologies. Biobetter products are designed to provide improved efficacy, safety, or convenience compared to existing treatments.
The Biobetter market is a rapidly growing sector of the biotechnology industry. Companies in this market are focused on developing and commercializing products that offer improved therapeutic benefits over existing treatments. These products are often developed through the use of advanced biotechnologies such as gene therapy, gene editing, and cell therapy.
Examples of companies in the Biobetter market include Moderna Therapeutics, Editas Medicine, and CRISPR Therapeutics. These companies are focused on developing and commercializing products that offer improved therapeutic benefits over existing treatments. Show Less Read more